Oseltamivir: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oseltamivir}} | |||
{{CMG}} | |||
==Overview== | |||
==Category== | |||
Antiviral | |||
==US Brand Names== | |||
TAMIFLU<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Oseltamivir description|Description]]''' | |||
'''| [[Oseltamivir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Oseltamivir microbiology|Microbiology]]''' | |||
'''| [[Oseltamivir indications and usage|Indications and Usage]]''' | |||
'''| [[Oseltamivir contraindications|Contraindications]]''' | |||
'''| [[Oseltamivir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Oseltamivir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Oseltamivir drug interactions|Drug Interactions]]''' | |||
'''| [[Oseltamivir overdosage|Overdosage]]''' | |||
'''| [[Oseltamivir clinical studies|Clinical Studies]]''' | |||
'''| [[Oseltamivir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Oseltamivir how supplied|How Supplied]]''' | |||
'''| [[Oseltamivir labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antiviral]] | |||
[[Category:Wikinfect]] | |||
Revision as of 14:50, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
Antiviral
US Brand Names
TAMIFLU®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages